Inventor · disambiguated record
Mehdi Lahmar
Also filed as: LAHMAR MEHDI · LAHMAR MEHDI MOURAD
3 granted patents·7 pending applications·3 citations·filing 2009–2022
57Inventor score
Top patents by PatentIndex Score
10 records- 0181US11643461B2Humanized, mouse or chimeric anti-CD47 monoclonal antibodiesFORTY SEVEN INC·Filed 2020·Granted May 9, 2023·1 cites·24 claims
- 0278US10927173B2Humanized, mouse or chimeric anti-CD47 monoclonal antibodiesFORTY SEVEN INC·Filed 2017·Granted Feb 23, 2021·2 cites·21 claims
- 0369US12060423B2Humanized, mouse or chimeric anti-CD47 monoclonal antibodiesFORTY SEVEN INC·Filed 2022·Granted Aug 13, 2024·0 cites·19 claims
- 0456US2022144959A1Amhrii-binding compounds for preventing or treating cancersGAMAMABS PHARMA·Filed 2021·Application pending·0 cites
- 0556US2023058171A1New oral pharmaceutical composition for cancer therapyBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 0642US2011251085A1In vitro method to determine whether a drug candidate active against a target protein is active against a variant of said proteinVIVALIS·Filed 2009·Application pending·0 cites
- 0740US2023001006A1Amhrii-binding antibody drug conjugates and their use thereof in the treatment of cancersGAMAMABS PHARMA·Filed 2020·Application pending·0 cites
- 0839US2019367625A1Amhrii-binding compounds for preventing or treating cancersGAMAMABS PHARMA·Filed 2019·Application pending·0 cites
- 0932US2020148777A1Cancer-associated immunosuppression inhibitorGAMAMABS PHARMA·Filed 2018·Application pending·0 cites
- 1031US2023227566A1Amhrii-binding compounds for preventing or treating lung cancersGAMAMABS PHARMA·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mehdi Lahmar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →